Quick verdict — when to pick which
Your team's output is digital ad creatives (Meta, Instagram, Google Display), you want self-serve pricing with a real free tier, and you need specific, actionable fix recommendations on each creative — not a research report.
You need a single platform that covers TV, print, OOH, packaging, and shopper research in addition to digital ads, you have enterprise procurement in place, and you value a longer track record of academic validation across non-ad formats.
Two products built for different buyers
Neurons and GazeIQ overlap on one idea: you can predict where viewers will look on a creative before you launch it, and that prediction is accurate enough to improve creative decisions. Beyond that shared premise, the two products are built for very different users.
Neurons is a broad creative research platform. It serves agencies, packaged-goods teams, retail designers, TV buyers, and media researchers. Its heritage is lab-based neuromarketing — EEG, eye tracking, biometric studies — which it has progressively automated into a software product. That makes it powerful for organizations running cross-format creative research programs.
GazeIQ is narrower by design. We serve performance marketers whose daily job is shipping Meta, Instagram, and Google Display creatives that convert. Everything from our scoring metrics to our recommendations to our platform mockups is scoped to that specific workflow. The narrowness is what lets us sell self-serve, hit sub-8 second scans, and offer a free tier you can start using before finishing this sentence.
Feature comparison: GazeIQ vs. Neurons
| Feature | Neurons | GazeIQ |
|---|---|---|
| Attention heatmap | Yes — neuroscience-informed prediction | Yes — TranSalNet, CC=0.907 on SALICON |
| Element-level scoring | Focus area and cognitive metrics | 5 named sub-metrics: CTA visibility, headline, hierarchy, edge, clutter |
| AI fix recommendations | General diagnostic output | Principle-based (Von Restorff, F-pattern, Z-pattern) with specific fixes |
| A/B pre-testing up to 5 variants | ||
| Platform-specific mockups | Broad formats incl. TV, OOH, print | Meta Feed, Instagram Story, Google Display |
| Pricing floor | Enterprise / custom contracts | Self-serve, monthly |
| Free tier | 3 scans, no credit card | |
| Time to insight | Seconds–minutes | Under 8 seconds |
| Primary use case | Cross-format creative research | Digital ad creative pre-testing |
| Ideal team size | Enterprise / large agency | Startup, growth, and mid-market |
Neurons feature descriptions based on publicly available product material; check their current pricing and scope at neuronsinc.com.
When Neurons is the better choice
We're not going to pretend GazeIQ is the right pick for every buyer who types "neurons alternative" into Google. Here are the cases where Neurons is genuinely the better fit:
When GazeIQ is the better choice
And here's where GazeIQ pulls ahead — the scenarios we built the product specifically to handle:
Can you use both?
In practice, almost no teams run both platforms in parallel — the overlap in attention prediction is too direct, and paying for two saliency engines is hard to justify. The buyers we see are clearly on one side of the line: either they need the full research-grade platform (Neurons) or they need an in-workflow pre-tester for performance ads (GazeIQ).
That said, if you already run Neurons as your enterprise research tool and want a self-serve, designer-accessible option for the day-to-day performance marketing team, GazeIQ can sit alongside without stepping on it. Research teams get Neurons for the quarterly deep dives; the growth team uses GazeIQ to pre-test every creative before it goes live.
Frequently asked questions
What is Neurons Predict?
Neurons (formerly Neurons Inc., with their core product often referred to as Neurons Predict) is a Danish neuroscience-based software platform that predicts attention and cognitive response to creative assets. It is used across advertising, packaging, retail design, TV, and out-of-home, typically sold on enterprise contracts to agencies and large brands.
Why look for a Neurons alternative?
The most common reasons are pricing and scope. Neurons is sold primarily on enterprise contracts with sales-led onboarding, which puts it out of reach for many growth and performance teams. It is also designed to cover a broad range of creative formats — TV spots, OOH, retail — which is powerful for research teams but overkill for marketers whose only job is shipping better Meta and Google ads.
Is GazeIQ a direct replacement for Neurons?
For digital ad creative analysis, yes — GazeIQ delivers the same core output (a predicted attention heatmap plus an overall score) and adds element-level sub-scores for CTA, headline, hierarchy, edge, and clutter that are tuned specifically for ad formats. For TV, print, OOH, or shopper research, Neurons' broader methodology and larger validation library are still the better fit.
How accurate is GazeIQ's attention prediction?
GazeIQ uses the TranSalNet saliency model, which reports a correlation coefficient of 0.907 on the SALICON eye-tracking benchmark — one of the strongest published scores for predicting where human viewers look on static images. In practice, that produces heatmaps that closely match lab-based eye tracking for digital ad creatives.
Does GazeIQ have a free tier?
Yes. GazeIQ offers 3 free scans with no credit card required, so you can run a real creative through the full pipeline — heatmap, Attention Score, sub-metrics, and AI recommendations — before deciding whether to upgrade. Neurons is typically evaluated via sales-led demos instead.